AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32412858 — intervention group
Group type: EXPERIMENTAL
Intervention: Medtronic MiniMed™ 640G Suspend before low feature
Number of subjects: 0
Study 35915956 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet-suction (WS) technique
Number of subjects: 210
Study 35915956 — intervention group
Group type: COMPARATOR
Intervention: Slow-pull (SP) technique
Number of subjects: 210
Study 33862350 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% pomegranate peel extract solution used with a pulsating jet irrigator
Number of subjects: 34
Study 33862350 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 34
Study 36431314 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal therapy (TG)
Number of subjects: 30
Study 36431314 — intervention group
Group type: COMPARATOR
Intervention: Mechanical plaque removal (CG)
Number of subjects: 30
Study 32030624 — intervention group
Group type: EXPERIMENTAL
Intervention: Inguinal approach for obturator nerve block
Number of subjects: 0
Study 32030624 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical approach for obturator nerve block
Number of subjects: 0
Study 35206569 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic intervention for 12 weeks, three times a week, in 45-min sessions
Number of subjects: 46
Study 35206569 — intervention group
Group type: COMPARATOR
Intervention: Control group (CFS) maintained their daily routines as normal
Number of subjects: 46
Study 35206569 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic intervention
Number of subjects: 46
Study 33582975 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 0
Study 33582975 — intervention group
Group type: EXPERIMENTAL
Intervention: Contemporary methods (Mendelian randomization and pharmaco-epidemiological research)
Number of subjects: 0
Study 33563509 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromobilization techniques (6-week conservative rehabilitation and radial nerve mobilization program)
Number of subjects: 40
Study 33563509 — intervention group
Group type: COMPARATOR
Intervention: Conservative rehabilitation therapy only (control group)
Number of subjects: 40
Study 34429197 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of rosuvastatin 2.5 mg and ezetimibe 10 mg (R2.5+E10)
Number of subjects: 279
Study 34429197 — intervention group
Group type: COMPARATOR
Intervention: Ezetimibe 10 mg monotherapy (E10)
Number of subjects: 279
Study 34429197 — intervention group
Group type: COMPARATOR
Intervention: Rosuvastatin 2.5 mg (R2.5)
Number of subjects: 279
Study 34429197 — intervention group
Group type: COMPARATOR
Intervention: Rosuvastatin 5 mg monotherapy (R5)
Number of subjects: 279
Study 33143722 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent use of a fasting-mimicking diet
Number of subjects: 0
Study 33143722 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 35357066 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet (LFD)
Number of subjects: 42
Study 35357066 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean diet (MedDiet)
Number of subjects: 42
Study 33477003 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness for Multiple Sclerosis (M4MS)
Number of subjects: 55
Study 33477003 — intervention group
Group type: EXPERIMENTAL
Intervention: Chair Yoga
Number of subjects: 55
Study 33477003 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 55
Study 32410652 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral food challenge (OFC)
Number of subjects: 4151
Study 32410652 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin prick test (SPT) and specific IgE (sIgE) measurement
Number of subjects: 4151
Study 32410652 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-reported food allergy
Number of subjects: 4151
Study 32410652 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall prevalence of food allergy
Number of subjects: 4151
Study 32410652 — intervention group
Group type: EXPERIMENTAL
Intervention: Common allergic manifestations
Number of subjects: 4151
Study 32410652 — intervention group
Group type: EXPERIMENTAL
Intervention: Common allergic foods
Number of subjects: 4151
Study 35413887 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)‐style chatbot (n=78)
Number of subjects: 153
Study 35413887 — intervention group
Group type: COMPARATOR
Intervention: Neutral chatbot (n=75)
Number of subjects: 153
Study 32130661 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal insulin-based treatment (insulin glargine plus OADs)
Number of subjects: 400
Study 32130661 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily premixed insulin (NovoLog® Mix 70/30)
Number of subjects: 400
Study 35505122 — intervention group
Group type: EXPERIMENTAL
Intervention: Aged garlic extract (AGE) 2.4 g
Number of subjects: 28
Study 35505122 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 28
Study 35505122 — intervention group
Group type: EXPERIMENTAL
Intervention: Aged garlic extract (AGE)
Number of subjects: 28
Study 32686262 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous skin cell suspension (ASCS) in combination with standard therapy
Number of subjects: 16
Study 32686262 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-related Quality of Life questionnaire
Number of subjects: 16
Study 32686262 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction scores from subjects and clinicians
Number of subjects: 16
Study 32686262 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety outcomes
Number of subjects: 16
Study 34225479 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-channeled nutrition education approach (both OFSP-branded materials for preschoolers and mobile phone mediated text messages for caregivers)
Number of subjects: 431
Study 34225479 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-channeled nutrition education approach (OFSP-branded materials for preschoolers only)
Number of subjects: 431
Study 34225479 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-channeled nutrition education approach (mobile phone mediated text messages for caregivers only)
Number of subjects: 431
Study 34225479 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine OFSP promotion activities)
Number of subjects: 431
Study 32437307 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic insights and shared genetic loci between T2D and CHD
Number of subjects: 0
Study 32437307 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization studies assessing whether T2D is causal for CHD
Number of subjects: 0
Study 36221306 — intervention group
Group type: EXPERIMENTAL
Intervention: START-Play intervention
Number of subjects: 112
Study 36221306 — intervention group
Group type: COMPARATOR
Intervention: Usual care - early intervention
Number of subjects: 112
Study 33969933 — intervention group
Group type: EXPERIMENTAL
Intervention: Atypical category
Number of subjects: 12
Study 33969933 — intervention group
Group type: EXPERIMENTAL
Intervention: Malignant category
Number of subjects: 12
Study 33969933 — intervention group
Group type: EXPERIMENTAL
Intervention: Atypical and suspicious for malignancy categories
Number of subjects: 12
Study 36691242 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental imagery audioguide session
Number of subjects: 309
Study 36691242 — intervention group
Group type: EXPERIMENTAL
Intervention: Part-task trainer simulation
Number of subjects: 309
Study 36691242 — intervention group
Group type: EXPERIMENTAL
Intervention: Written instructions
Number of subjects: 309
Study 33044432 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 214
Study 33044432 — intervention group
Group type: COMPARATOR
Intervention: Control (standard protocol without N-acetylcysteine)
Number of subjects: 214
Study 36446888 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm donor human milk (DHM)
Number of subjects: 102
Study 36446888 — intervention group
Group type: COMPARATOR
Intervention: Term donor human milk (DHM)
Number of subjects: 102
Study 33857201 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia group (nondependent lung not ventilated for 2 min, then ventilated for 2 min, repeated five times)
Number of subjects: 136
Study 33857201 — intervention group
Group type: COMPARATOR
Intervention: Continuous normoxia group (both lungs ventilated for 20 min)
Number of subjects: 136
Study 33857201 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia group
Number of subjects: 136
Study 33857201 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 136
Study 35724966 — intervention group
Group type: EXPERIMENTAL
Intervention: Drinks:Ration mobile app
Number of subjects: 123
Study 35724966 — intervention group
Group type: COMPARATOR
Intervention: Control mobile app (government guidance only)
Number of subjects: 123
Study 32156749 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (PGH arm)
Number of subjects: 64
Study 32156749 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine and nab-paclitaxel (PG arm)
Number of subjects: 64
Study 36199101 — intervention group
Group type: EXPERIMENTAL
Intervention: HMD‐VR
Number of subjects: 36
Study 36199101 — intervention group
Group type: COMPARATOR
Intervention: CS
Number of subjects: 36
Study 36199101 — intervention group
Group type: EXPERIMENTAL
Intervention: HMD‐VR to CS
Number of subjects: 36
Study 34120616 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural arm providing information about the child’s possible emotions and behaviour during and after admission, and providing age appropriate games for the caregiver and child.
Number of subjects: 120
Study 34120616 — intervention group
Group type: COMPARATOR
Intervention: Psycho-educational arm providing information about hospital procedures during admission.
Number of subjects: 120
Study 32695822 — intervention group
Group type: EXPERIMENTAL
Intervention: EVD weaning trial with monitoring of intracranial pressure (ICP)
Number of subjects: 37
Study 32695822 — intervention group
Group type: EXPERIMENTAL
Intervention: EVD weaning trial with ICP burden above 20 mmHg
Number of subjects: 37
Study 32695822 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiver operating characteristic analyses for delta ICP
Number of subjects: 37
Study 32695822 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiver operating characteristic analyses for ICP burden >20 mmHg
Number of subjects: 37
Study 36222863 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia (three 4-min hypoxic cycles at 80% arterial oxygen saturation interspersed with 4-min room air cycles)
Number of subjects: 12
Study 36222863 — intervention group
Group type: COMPARATOR
Intervention: Intermittent normoxia (three 4-min normoxic cycles separated by 4-min room air cycles)
Number of subjects: 12
Study 33089537 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management support intervention (8 sessions over 4 weeks)
Number of subjects: 40
Study 33089537 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 40
Study 32719355 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP)
Number of subjects: 0
Study 32719355 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33783059 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation (CR) plus Treatment as Usual (TAU)
Number of subjects: 65
Study 33783059 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 65
Study 33902655 — intervention group
Group type: EXPERIMENTAL
Intervention: Online questionnaire administration
Number of subjects: 36
Study 33902655 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical measurements (strength and range of motion, mid‐foot mobility, palpation, ultrasound assessment of plantar fascia)
Number of subjects: 36
Study 33902655 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound assessment of plantar fascia
Number of subjects: 36
Study 33902655 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded loading challenge
Number of subjects: 36
Study 616952074 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of paracetamol 1000mg
Number of subjects: 34
Study 616952074 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of paracetamol 1000mg
Number of subjects: 34
Study 36255178 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 70
Study 36255178 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 70
Study 33969764 — intervention group
Group type: EXPERIMENTAL
Intervention: Paravertebral intramuscular Ozone injection
Number of subjects: 30
Study 33969764 — intervention group
Group type: COMPARATOR
Intervention: Caudal epidural steroid-hyaluronidase injection
Number of subjects: 30
Study 32384905 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot exercise plus education
Number of subjects: 20
Study 32384905 — intervention group
Group type: COMPARATOR
Intervention: Brief advice
Number of subjects: 20
Study 35765018 — intervention group
Group type: EXPERIMENTAL
Intervention: PACE intervention
Number of subjects: 61
Study 35765018 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 61
Study 32926540 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomarker panel for dietary exposure assessment
Number of subjects: 34
Study 32926540 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative relationships between biomarker concentrations
Number of subjects: 34
Study 34970741 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous low molecular weight heparin (LMWH) injection after coolant spray application in the leg region
Number of subjects: 50
Study 34970741 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous low molecular weight heparin (LMWH) injection after coolant spray application in the abdominal region
Number of subjects: 50
Study 34970741 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous low molecular weight heparin (LMWH) injection after coolant spray application in the arm region
Number of subjects: 50
Study 34970741 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous low molecular weight heparin (LMWH) injection after coolant spray application in the abdominal and arm regions
Number of subjects: 50
Study 33518395 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient single-agent regimen (Group A): cefazolin sodium 1g preoperatively and every eight hours for 48 hours postoperatively
Number of subjects: 100
Study 33518395 — intervention group
Group type: COMPARATOR
Intervention: Extended dual-agent regimen (Group B): cefazolin sodium 1g preoperatively and every eight hours for 48 hours postoperatively, followed by oral amoxicillin for three days
Number of subjects: 100
Study 36259684 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine supplemented with pregabalin
Number of subjects: 140
Study 36259684 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin supplemented with amitriptyline
Number of subjects: 140
Study 36259684 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (weeks 6-16)
Number of subjects: 140
Study 36259684 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline supplemented with pregabalin
Number of subjects: 140
Study 33588408 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) or other interventions for sleep apnea (exact dosage and duration not specified)
Number of subjects: 0
Study 33588408 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal transplantation
Number of subjects: 0
Study 33118908 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) delivered by trained lay health workers; 8 sessions
Number of subjects: 50
Study 33118908 — intervention group
Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 50
Study 35787522 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled treprostinil
Number of subjects: 792
Study 35787522 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 792
Study 34052065 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 µg recombinant hepatitis B vaccine (IM20 group)
Number of subjects: 182
Study 34052065 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 µg recombinant hepatitis B vaccine (IM60 group)
Number of subjects: 182
Study 35964661 — intervention group
Group type: EXPERIMENTAL
Intervention: Delivery room insertion of etonogestrel implant (0 to 2 hours postdelivery)
Number of subjects: 95
Study 35964661 — intervention group
Group type: COMPARATOR
Intervention: Delayed insertion of etonogestrel implant (24 to 48 hours postdelivery)
Number of subjects: 95
Study 35964661 — intervention group
Group type: EXPERIMENTAL
Intervention: Delivery room insertion of etonogestrel implant
Number of subjects: 95
Study 35964661 — intervention group
Group type: COMPARATOR
Intervention: Delayed insertion of etonogestrel implant
Number of subjects: 95
Study 35964661 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 95
Study 33544985 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd:YAG laser activation of 40% H2O2
Number of subjects: 80
Study 33544985 — intervention group
Group type: EXPERIMENTAL
Intervention: 810-nm diode laser activation of 40% H2O2
Number of subjects: 80
Study 33544985 — intervention group
Group type: EXPERIMENTAL
Intervention: LED activation of 40% H2O2
Number of subjects: 80
Study 33544985 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional (chemical) treatment of 40% H2O2
Number of subjects: 80
Study 34387114 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 0
Study 34387114 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (low doses)
Number of subjects: 0
Study 34387114 — intervention group
Group type: COMPARATOR
Intervention: Prednisone (40 mg or equivalent)
Number of subjects: 0
Study 33772364 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual integrative oncology treatments (e.g., live-streamed or on-demand programs, one-on-one virtual appointments for acupressure and self-care massage)
Number of subjects: 16366
Study 33772364 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual consent and intervention delivery for integrative oncology studies (Yoga and Music Therapy)
Number of subjects: 16366
Study 32164613 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic clip application (group A)
Number of subjects: 116
Study 32164613 — intervention group
Group type: COMPARATOR
Intervention: No prophylactic clip application (group B)
Number of subjects: 116
Study 34988702 — intervention group
Group type: EXPERIMENTAL
Intervention: EVOH-Onyx® (group 1, n=3)
Number of subjects: 9
Study 34988702 — intervention group
Group type: EXPERIMENTAL
Intervention: Microspheres 500 µ (group 2, n=3)
Number of subjects: 9
Study 34988702 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-mm micro-coils (group 3, n=3)
Number of subjects: 9
Study 35536640 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth program (self-regulation component, narrative, and chatbot)
Number of subjects: 186
Study 35536640 — intervention group
Group type: EXPERIMENTAL
Intervention: self-regulation and narrative components
Number of subjects: 186
Study 35536640 — intervention group
Group type: EXPERIMENTAL
Intervention: chatbot use
Number of subjects: 186
Study 35536640 — intervention group
Group type: COMPARATOR
Intervention: nonacademic educational track
Number of subjects: 186
Study 35536640 — intervention group
Group type: EXPERIMENTAL
Intervention: reasons for nonusage attrition
Number of subjects: 186
Study 33081828 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (1-h intravenous infusion)
Number of subjects: 80
Study 33081828 — intervention group
Group type: COMPARATOR
Intervention: Placebo (NaCl)
Number of subjects: 80
Study 35364216 — intervention group
Group type: EXPERIMENTAL
Intervention: CTP-543 4 mg twice daily
Number of subjects: 0
Study 35364216 — intervention group
Group type: EXPERIMENTAL
Intervention: CTP-543 8 mg twice daily
Number of subjects: 0
Study 35364216 — intervention group
Group type: EXPERIMENTAL
Intervention: CTP-543 12 mg twice daily
Number of subjects: 0
Study 35364216 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35150488 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatric patients' belief in demonic possession as associated with psychiatric illness
Number of subjects: 408
Study 35150488 — intervention group
Group type: EXPERIMENTAL
Intervention: Desire for a priest in the therapeutic team among psychiatric patients
Number of subjects: 408
Study 35150488 — intervention group
Group type: COMPARATOR
Intervention: Attendance of religious services among psychiatrists
Number of subjects: 408
Study 35010938 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive medical nutrition therapy (MNT) plus metformin (850 mg twice/day)
Number of subjects: 90
Study 35010938 — intervention group
Group type: COMPARATOR
Intervention: Intensive medical nutrition therapy (MNT) without metformin
Number of subjects: 90
Study 35322793 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 54
Study 35322793 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 54
Study 35322793 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzbromarone
Number of subjects: 54
Study 35322793 — intervention group
Group type: COMPARATOR
Intervention: Combination of empagliflozin and benzbromarone
Number of subjects: 54
Study 33186771 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine Toxin Botulinic injections (BTX) under hysteroscopy (200 IU of Incobotulinum-toxin A)
Number of subjects: 30
Study 33186771 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine Toxin Botulinic injections (BTX) under hysteroscopy
Number of subjects: 30
Study 35019175 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronedarone 400 mg twice daily
Number of subjects: 0
Study 35019175 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32517728 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclinical pulmonary emphysema
Number of subjects: 687
Study 32517728 — intervention group
Group type: COMPARATOR
Intervention: Cigarette smoking
Number of subjects: 687
Study 32517728 — intervention group
Group type: COMPARATOR
Intervention: Family history of lung disease
Number of subjects: 687
Study 32517728 — intervention group
Group type: COMPARATOR
Intervention: Lower body mass index
Number of subjects: 687
Study 32517728 — intervention group
Group type: COMPARATOR
Intervention: Telomere length and Klotho serum concentration
Number of subjects: 687